Sanofi Proposes Appointment of New Independent Directors
Provided by
Dow Jones
By Nina Kienle
Sanofi said it would propose the appointment of new independent directors, as Diane Souza, and Thomas Suedhof intend to leave at the end of their second terms.
The French pharmaceutical company said late Thursday that it plans to propose the appointment of Clotilde Delbos, Anne-Francoise Nesmes and John Sundy as independent directors as well as the renewal of the terms of office of Rachel Duan and Lise Kingo.
Write to Nina Kienle at nina.kienle@wsj.com
(END) Dow Jones Newswires
February 23, 2024 04:59 ET (09:59 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth